Zorevunersen in Children and Adolescents with Dravet Syndrome

The article addresses the use of zorevunersen in children and adolescents with Dravet syndrome. Dravet syndrome is a rare and severe form of epilepsy that typically appears in early childhood. Zorevunersen is a new therapeutic approach designed to treat this condition. The study was published in the prestigious New England Journal of Medicine in June 2026. The research focuses on the safety and efficacy of this medication in the pediatric population. This drug represents a potential advancement in the treatment of this serious neurological disorder.